HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired autophagy and delayed autophagic clearance of transforming growth factor β-induced protein (TGFBI) in granular corneal dystrophy type 2.

Abstract
Granular corneal dystrophy type 2 (GCD2) is an autosomal dominant disease characterized by a progressive age-dependent extracellular accumulation of transforming growth factor β-induced protein (TGFBI). Corneal fibroblasts from GCD2 patients also have progressive degenerative features, but the mechanism underlying this degeneration remains unknown. Here we observed that TGFBI was degraded by autophagy, but not by the ubiquitin/proteasome-dependent pathway. We also found that GCD2 homozygous corneal fibroblasts displayed a greater number of fragmented mitochondria. Most notably, mutant TGFBI (mut-TGFBI) extensively colocalized with microtubule-associated protein 1 light chain 3β (MAP1LC3B, hereafter referred to as LC3)-enriched cytosolic vesicles and CTSD in primary cultured GCD2 corneal fibroblasts. Levels of LC3-II, a marker of autophagy activation, were significantly increased in GCD2 corneal fibroblasts. Nevertheless, levels of SQSTM1/p62 and of polyubiquitinated protein were also significantly increased in GCD2 corneal fibroblasts compared with wild-type (WT) cells. However, LC3-II levels did not differ significantly between WT and GCD2 cells, as assessed by the presence of bafilomycin A 1, the fusion blocker of autophagosomes and lysosomes. Likewise, bafilomycin A 1 caused a similar change in levels of SQSTM1. Thus, the increase in autophagosomes containing mut-TGFBI may be due to inefficient fusion between autophagosomes and lysosomes. Rapamycin, an autophagy activator, decreased mut-TGFBI, whereas inhibition of autophagy increased active caspase-3, poly (ADP-ribose) polymerase 1 (PARP1) and reduced the viability of GCD2 corneal fibroblasts compared with WT controls. These data suggest that defective autophagy may play a critical role in the pathogenesis of GCD2.
AuthorsSeung-Il Choi, Bong-Yoon Kim, Shorafidinkhuja Dadakhujaev, Jun-Young Oh, Tae-Im Kim, Joo Young Kim, Eung Kweon Kim
JournalAutophagy (Autophagy) Vol. 8 Issue 12 Pg. 1782-97 (Dec 2012) ISSN: 1554-8635 [Electronic] United States
PMID22995918 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Extracellular Matrix Proteins
  • Mutant Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein
  • Caspase 3
  • Sirolimus
Topics
  • Adult
  • Autophagy (drug effects)
  • Biomarkers (metabolism)
  • Caspase 3 (metabolism)
  • Cell Death (drug effects)
  • Cell Survival (drug effects)
  • Child
  • Cornea (drug effects, metabolism, pathology)
  • Corneal Dystrophies, Hereditary (metabolism, pathology)
  • Enzyme Activation (drug effects)
  • Extracellular Matrix Proteins (metabolism)
  • Female
  • Fibroblasts (metabolism, pathology, ultrastructure)
  • Humans
  • Intracellular Space (drug effects, metabolism)
  • Kinetics
  • Lysosomes (drug effects, metabolism)
  • Male
  • Membrane Fusion (drug effects)
  • Middle Aged
  • Mutant Proteins (metabolism)
  • Phagosomes (drug effects, metabolism)
  • Proteolysis (drug effects)
  • Sirolimus (pharmacology)
  • Transforming Growth Factor beta (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: